Digital Innovation in Pharma: What Will 2026 Bring?
This year will be the turning point from AI “hype” to the adoption of meaningful AI and digital health solutions in pharma. Here four predictions.
How AI Is Helping Psychiatrists Make Faster, Smarter Treatment Decisions
Clinical trials, real-world data and digital biomarkers are turning artificial intelligence into a practical ally in the fight against depression.
presented by
Esperion Sets Its Sights on New Areas While Maintaining Commitment to Cardiovascular Health
In a recent interview, Esperion president and CEO, Sheldon Koenig talks about the reality of statin intolerance and his company’s expansion into new diseases
Why Consumers Should Care About Biomarkers — And How Technology Developers and Manufacturers Can Bridge the Gap
More precise and consumer-friendly biomarker detection technologies are coming to market at a pace that can help users gain rich insight into their health and well-being from anywhere and at any time. This is especially important when it comes to preventive healthcare.
Digital Biomarkers: The Key to Delivering on the Promise of Personalized Medicine
Digital biomarkers today serve as a valuable monitoring tool, providing details about a patient’s general health and response to treatment. But, as technology continues to develop, they could fuel predictive insights about a patient’s future health outcomes and disease trajectory, as well as demonstrate measurable quality of life improvements.
Digital biomarkers: Lots of potential, but where’s the validation?
There's still a gap between potential and validation when it comes to digital biomarkers.